Brefeldin A
| Names | |
|---|---|
| Preferred IUPAC name
 (1R,2E,6S,10E,11aS,13S,14aR)-1,13-Dihydroxy-6-methyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f][1]oxacyclotridecin-4-one  | |
| Other names
 γ,4-Dihydroxy-2-(6-hydroxy-1-heptenyl)-4-cyclopentanecrotonic acid λ-lactone  | |
| Identifiers | |
3D model (JSmol)  | 
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.127.053 | 
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
  | |
  | |
| Properties | |
| C16H24O4 | |
| Molar mass | 280.36 g/mol | 
| Appearance | White to off-white crystalline powder | 
| Melting point | 204 to 205 °C (399 to 401 °F; 477 to 478 K) | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Brefeldin A is a lactone antiviral produced by the fungus Penicillium brefeldianum. Brefeldin A inhibits protein transport from the endoplasmic reticulum to the golgi complex indirectly by preventing association of COP-I coat to the Golgi membrane. Brefeldin A was initially isolated with hopes to become an antiviral drug but is now primarily used in research to study protein transport.